Efficacy of dienogest in the treatment of endometrioma‐related pain and subfertility

Eighteen months of dienogest treatment was highly effective, safe, and tolerable in reducing endometrioma-related pelvic pain, improving sexual dysfunction due to endometrioma, volume of endometrioma, and markers of ovarian reserve. In conclusion, dienogest can be used in infertile patients before surgery or oocyte retrieval to reduce the risk of abscesses and infections. Long-term dienogest treatment in young women with no desire for pregnancy in the short term might reduce the likelihood of surgery later in life and the risk of loss of ovarian reserve due to repeated surgery, while increasing the likelihood of fertilization.